LexDanaLexDanabeta
Inventor

Sina Bavari

Inventor
Frederick, MD, US

Overview

29→
Patents
2002–2017
Patent span
Chemistry
Primary field (CPC C)

Patents· 29 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C12NMicroorganisms or enzymes19%
C07KPeptides15%
A61KPreparations for medical, dental or toiletry purposes9%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
C07HSugars7%
C07DHeterocyclic compounds3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
G16CComputational chemistry3%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
9,597,326'Benzonapthyridine compositions and uses thereof'20179,347,951'Fusion protein comprising the extracellular domain of a filovirus glycoprotein fused to an immunoglobulin heavy chain constant region'20169,187,516'Compositions and methods for inhibiting expression of a gene from the Ebola virus'20158,936,915'Cleavage sensitive antibodies and methods of use thereof'20158,912,316'Compositions and methods for inhibiting expression of CD45 gene'20148,735,369'Compositions and methods for inhibiting expression of a gene from the Ebola virus'20148,710,185'Bacterial superantigen vaccines'20148,691,859'Broad spectrum antibacterial compounds'20148,354,390'Compositions and methods for inhibiting expression of a gene from the ebola virus'20138,288,525'Compositions and methods for inhibiting expression of CD45 gene'20128,168,604'Antisense antiviral compounds and methods for treating a filovirus infection'20128,067,202'Bacterial superantigen vaccines'20118,030,291'Antisense antiviral compounds and methods for treating a filovirus infection'20118,030,292'Antisense antiviral compounds and methods for treating a filovirus infection'20117,999,001'Antiviral compounds and methods of using thereof'20117,973,020'Compositions and methods for inhibiting expression of a gene from the ebola virus'20117,879,330'Antibodies against type A botulinum neurotoxin'20117,825,154'Small molecule inhibitors of botulinum neurotoxins'20107,781,183'Inhibition of anthrax lethal factor protease'20107,759,320'Compositions and methods for inhibiting expression of a gene from the Ebola'20107,682,618'Generation of virus-like particles and use as panfilovirus vaccine'20107,574,340'Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof'20097,524,829'Antisense antiviral compounds and methods for treating a filovirus infection'20097,507,196'Antisense antiviral compounds and methods for treating a filovirus infection'20097,378,257'Bacterial superantigen vaccines'20087,049,085'Antibodies against type a botulinum neurotoxin'20066,713,284'Bacterial superantigen vaccines'20046,667,158'Antibodies against type a botulinum neurotoxin'20036,399,332'Bacterial superantigen vaccines'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2015Patents assigned to US ARMY (19)· patent assignee history
2002–2014Based in Dillsburg, PA, US· patent location history
2003–2016Based in Frederick, MD, US· patent location history
2009–2012Patents assigned to AVI BIOPHARMA INC (5)· patent assignee history
2010–2015Patents assigned to ALNYLAM PHARMACEUTICALS INC (7)· patent assignee history
2011–2017Patents assigned to BAVARI SINA (10)· patent assignee history
2012–2014Patents assigned to BORODOVSKY ANNA (3)· patent assignee history
2017Based in Fredrick, MD, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
US ARMY192002–2015
BAVARI SINAself102011–2017
ALNYLAM PHARMACEUTICALS INC72010–2015
AVI BIOPHARMA INC52009–2012
BORODOVSKY ANNA32012–2014
Locations
LocationPatentsSpan
Frederick, Maryland, US232003–2016
Dillsburg, Pennsylvania, US52002–2014
Fredrick, Maryland, US12017